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The REFLECT Statement: Methods and Processes of Creating Reporting
Guidelines for Randomized Controlled Trials for Livestock and Food
Safety by Modifying the CONSORT Statement
Abstract
The conduct of randomized controlled trials in livestock with production, health and food-safety outcomes
presents unique challenges that may not be adequately reported in trial reports. The objective of this project
was to modify the CONSORT (Consolidated Standards of Reporting Trials) statement to reflect the unique
aspects of reporting these livestock trials. A 2-day consensus meeting was held on 18–19 November 2008 in
Chicago, IL, USA, to achieve the objective. Prior to the meeting, a Web-based survey was conducted to
identify issues for discussion. The 24 attendees were biostatisticians, epidemiologists, food-safety researchers,
livestock-production specialists, journal editors, assistant editors and associate editors. Prior to the meeting,
the attendees completed a Web-based survey indicating which CONSORT statement items may need to be
modified to address unique issues for livestock trials. The consensus meeting resulted in the production of the
REFLECT (Reporting Guidelines for Randomized Control Trials) statement for livestock and food safety
and 22-item checklist. Fourteen items were modified from the CONSORT checklist and an additional sub-
item was proposed to address challenge trials. The REFLECT statement proposes new terminology, more
consistent with common usage in livestock production, to describe study subjects. Evidence was not always
available to support modification to or inclusion of an item. The use of the REFLECT statement, which
addresses issues unique to livestock trials, should improve the quality of reporting and design for trials
reporting production, health and food-safety outcomes.
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Summary
The conduct of randomized controlled trials in livestock with production,
health and food-safety outcomes presents unique challenges that may not be
adequately reported in trial reports. The objective of this project was to modify
the CONSORT (Consolidated Standards of Reporting Trials) statement to
reflect the unique aspects of reporting these livestock trials. A 2-day consensus
meeting was held on 18–19 November 2008 in Chicago, IL, USA, to achieve
the objective. Prior to the meeting, a Web-based survey was conducted to iden-
tify issues for discussion. The 24 attendees were biostatisticians, epidemiolo-
gists, food-safety researchers, livestock-production specialists, journal editors,
assistant editors and associate editors. Prior to the meeting, the attendees com-
pleted a Web-based survey indicating which CONSORT statement items may
need to be modified to address unique issues for livestock trials. The consensus
meeting resulted in the production of the REFLECT (Reporting Guidelines
for Randomized Control Trials) statement for livestock and food safety and
22-item checklist. Fourteen items were modified from the CONSORT checklist
and an additional sub-item was proposed to address challenge trials. The
REFLECT statement proposes new terminology, more consistent with common
usage in livestock production, to describe study subjects. Evidence was not
always available to support modification to or inclusion of an item. The use of
the REFLECT statement, which addresses issues unique to livestock trials,
should improve the quality of reporting and design for trials reporting produc-
tion, health and food-safety outcomes.
Impacts
• Guidelines for reporting randomized controlled trials should improve the
comprehensiveness of reporting.
• Improved reporting should increase readers ability to assess the internal
and external validity of study results.
• Improved reporting should increase the potential for study results to be
incorporated in decision making.
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Randomized controlled trials (RCT) are considered the
gold standard for evaluation of the efficacy of inter-
ventions in human and veterinary medicine. In human
medicine, inconsistencies with the reporting of inter-
vention studies have been documented over the past
10–15 years (DerSimonian et al., 1982; Pocock et al.,
1987; Gotzsche, 1989; Schulz et al., 1994; Sonis and
Joines, 1994; Ah-See and Molony, 1998). To address these
deficiencies, several initiatives were implemented to
improve the transparency of the conduct and reporting of
intervention studies. The best-known initiative is the
CONSORT statement (Consolidated Standards of Report-
ing Trials). The CONSORT statement was published in
1996 (Begg et al., 1996) with a revised version published
in multiple journals in 2001 (Moher et al., 2001a,b,c,d).
The CONSORT statement is based on a two-group paral-
lel design. Extensions of the CONSORT statement deal
with the unique features of different designs, such as clus-
ter trials (Campbell et al., 2004, 2005, 2006) harms (Ioan-
nidis et al., 2004) herbal interventions (Gagnier et al.,
2005, 2006a,b,c) and non-pharmacological interventions
(Boutron et al., 2008a). These CONSORT statements are
intended to improve the reporting of RCTs and conse-
quently to assist readers in understanding a trial’s design,
conduct, analysis and interpretation and in assessing the
internal and external validity of a trial’s results. The
CONSORT statement emphasizes that this can only be
achieved through complete transparency from authors.
The revision of the original CONSORT statement and the
subsequent extension for cluster trials has been adopted
as the standard by at least 100 medical journals. There is
evidence that use of the CONSORT statement in human
medical journals has improved the quality of reporting of
RCTs (Plint et al., 2006; Kane et al., 2007).
The issue of inferior quality of veterinary RCT reports
was first raised in editorials and commentaries in veteri-
nary journals in the early to mid-1990s (Chanter and
Wood, 1994; Elbers and Schukken, 1995; Higgins, 1997).
Recently, several systematic reviews of therapeutic,
preventive and food-safety trials in livestock species have
highlighted the need for better reporting (O’Connor
et al., 2006, 2008; Sargeant et al., 2007; Wellman and
O’Connor, 2007; Burns and O’Connor, 2008). Better
design, analysis and reporting are critical to having a
high-quality body of evidence that can be used for better
decision making. Although the use of the 22-item check-
list from the CONSORT statement could form the basis
of an instrument to improve the quality of reporting for
trials in livestock species, there are differences between
human and livestock trials that necessitate some modifi-
cations to the existing CONSORT statement to maxi-
mize the benefits of its use for livestock species. The
differences include two types of ‘participants’ (the ani-
mals’ owners/managers who consented to participate in a
trial, and the animals which are the actual study subjects),
the common use of clustered study designs, the use of a
deliberate challenge to animals with infectious agents in
some trials (a.k.a. challenge trials) and non-clinical out-
comes (e.g. production indices). These differences make
the direct use of the CONSORT statement challenging.
The aim of this report was to describe the methods
and processes used to develop an extension of the CON-
SORT statement that could form the basis for standard-
ized reporting guidelines for trials using livestock and
that addresses issues unique to livestock research with
production, health and food-safety outcomes.
Methods
The process for extending the CONSORT statement to
other applications is well documented (Boutron et al.,
2008b; Hopewell et al., 2008). We used these reports to
design the approach used for the modification reported
here.
Steering committee
A steering committee was responsible for the develop-
ment of the revised CONSORT statement. This group of
six members was formed in March 2008. The committee
agreed on the need to modify the original CONSORT
statement and to use the approach reported previously as
the guideline for the modification (Boutron et al., 2008b).
The committee secured funding for the project, identified
potential participants, invited the potential participants to
attend a consensus meeting, organized the meeting and
was responsible for subsequent steps involved in report
preparation and publication.
Funding
Funding was required to cover the costs of the consensus
meeting (e.g. travel, accommodation, meeting rooms). The
decision was made by the steering committee not to seek
funding from pharmaceutical or biological companies
commonly associated with livestock production. Efforts to
obtain funding were limited to government agencies and
not-for-profit, non-government organizations. Funding
was received from the USDA Food Safety and Response
Network (Grant 2005-35212-15287), National Pork Board;
Laboratory for Foodborne Zoonoses (Public Health
Agency of Canada), Applied Public Health Research Chair
program sponsored by the Canadian Institutes of Health
Research’s Institute of Population and Public Health and
the Public Health Agency of Canada, The Association for
Veterinary Epidemiology and Preventive Medicine and
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The American Meat Institute Foundation. Sufficient funds
were obtained to pay for all expenses for the participants
at the consensus meeting. Sufficient money was not
obtained to fund travel costs for all participants; therefore,
some participants funded their own travel and the source
of these funds was not identified.
Identification of participants
The committee’s aim was to bring together a group of
experts familiar with field trials or challenge studies in
livestock species with production, health and food-safety
outcomes. Another aim was to include at least one repre-
sentative from each major animal-protein production
system (beef, dairy, swine, poultry and aquaculture).
Representation from major livestock-trading nations was
also solicited because of different regulations governing
interventions for protein-based foods around the world.
The end users of the data, including but not limited to
editors, government officials and risk assessors were also
represented.
The committee decided to limit the size of the meeting
to 26 participants, including the six committee members.
The size limitation was arbitrary, but based on funding
and the need for a group size that facilitated interaction.
Using the previously described criteria for the desired
mix of participants, the steering committee identified 20
experts, many with multiple areas of expertise, for invita-
tion. The list of 20 experts was divided among the steering
committee members, who then extended an invitation to
the experts. When the initial invitation was declined, the
committee discussed an alternate who was then contacted.
Identification of specific issues
Using the approach described previously (Boutron et al.,
2008b) a survey was sent to the invitees and committee
members soliciting input on each CONSORT statement
checklist item to improve relevance to livestock health,
production and food safety. This survey was administered
by staff at Iowa State University and was granted an
exception from human subjects’ approval by the ISU
institutional review board. The survey included the 22
items of the original CONSORT statement and asked the
participants to indicate if each item should be modified
(yes/no) and if yes, to describe the rationale for modifica-
tion. The survey was administered using Web-based soft-
ware, or the participants could fill out a Microsoft Word
copy of the survey and return it to a member of the
steering committee.
After the surveys were returned, the responses for each
checklist item were compiled. This included the number
of respondents who had indicated yes/no for modification
and the associated comments. The names of the partici-
pants were removed from their comments.
Boutron et al. (2008b) ranked the CONSORT checklist
items based on the number of ‘votes’ for modification;
however, ranking was not carried out prior to this partic-
ular meeting. The rationale for modifying the approach
was to allow more discussion about the items and to
ensure that issues with few comments were also consid-
ered at the meeting.
The consensus meeting
A 2-day consensus meeting was held on 18–19 November
2008, in Chicago, IL, USA. At the meeting, participants
were provided with the following materials: (i) a copy of
the CONSORT statement (Moher et al., 2001c); (ii) a
copy of the CONSORT explanation and elaboration doc-
ument (Altman et al., 2001); and (iii) a copy of the docu-
ment describing the process of modifying the CONSORT
statement for extensions to an additional application
(Boutron et al., 2008b). The participants were also pro-
vided with a complete list of the comments from the
Web-based survey and a list describing how often each
CONSORT item had been reported in a study of 100 live-
stock trials reporting production or health outcomes, and
100 trials reporting pre-harvest food-safety outcomes
(Sargeant et al., 2009a,b).
The meeting began with several presentations about the
CONSORT statement, the results from the reviews of
livestock-trial reporting and a discussion of the approach
to reaching consensus that would be used. Three voting
criteria were suggested and discussed as indicators of con-
sensus: 100% of participants must agree, >80% of partici-
pants must agree or a simple majority (>50%). A secret
ballot was taken to determine the level of agreement that
would represent consensus. Participants indicated their
preference on a blank piece of paper. The ballots were
collected, counted and reported to the group.
For the remainder of the meeting, the following
approach was used for CONSORT checklist items 1–22.
First, the participants were divided into three groups
(determined by the steering committee) to include a mix
of expertise from each subgroup (biostatisticians, epide-
miologist, food-safety researchers, livestock-production
specialists) and asked to discuss a CONSORT checklist
item. At the end of the time designated for discussion
(approximately 20 min per item), representatives from
each group presented the opinions of the group. After
all groups had presented their opinions, a discussion
followed and a proposed modification (or not) was
drafted. Each group kept notes of the discussion, which
included many comments about issues that should be
included in the explanation and elaboration document.
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The discussion sessions were moderated by one of two
members of the steering committee (AOC and JMS). At
the end of discussion, participants were asked to vote yes
or no for the proposed item (modification or not) and
paper ballots were collected, counted and reported to the
group. If an item received sufficient votes to indicate
consensus, it was accepted; if it did not, it was tabled for
further discussion at the end of the meeting.
Preparation of reporting guidelines
After the meeting, the steering committee compiled a
draft report of the meeting, which included the proposed
modifications, an explanation and elaboration document,
and a request for feedback from participants. The steering
committee collated the comments and suggested revisions
and then developed the modified CONSORT statement
for trials in livestock species with production, health and
food-safety outcomes.
Results
Twenty-four experts were invited and 20 accepted, but
one subsequently was unable to attend. Of the six steer-
ing-committee members, five attended. The meeting was
attended by 24 experts (19 invitees and five steering
committee members), as well as a post-doctoral fellow
working for one of the steering-committee members
(JMS) and one record keeper. The 24 experts included
biostatisticians, epidemiologists, food-safety researchers
and livestock-production specialists. Some participants
had multiple areas of expertise. Among the group mem-
bers, seven were journal editors or assistant/associate edi-
tors. One participant was working in Australia, another in
Germany; five were working in Canada, and the remain-
der in the United States. One expert worked almost
exclusively in poultry production and food safety, one
expert was familiar with aquaculture (although not exclu-
sively), five worked extensively on food safety and/or
production issues in beef production, three worked exten-
sively on food safely and/or production in swine, and five
worked extensively in dairy food safety and/or produc-
tion. The group included two PhD-level statisticians with
many years experience in livestock-industry research. Five
participants frequently conducted challenge trials with
production and food-safety outcomes. Three participants
were employed by government agencies.
The pre-meeting, Web-based survey was completed by
25 of the invited experts and steering-committee mem-
bers; however, two invitees provided the responses on the
day before the meeting, and these could not be incor-
porated into the materials for the meeting. All of the
steering-committee members completed the Web-based
survey. The results of the survey are presented in Table 1.
It was unclear why respondents did not answer some
questions. This might have been related to the individual
respondent’s level of familiarity with specific CONSORT
statement items prior to the meeting or to an individual’s
area of expertise, e.g. some participants may not have felt
qualified to comment on the presentation of statistical
methods.
Voting rights were extended to everyone at the meeting
except the record keeper. The moderators for the item
discussion sessions (AOC and JMS) abstained from voting
for the CONSORT-item modifications. It was decided
that >80% of votes would represent consensus. Hence,
with two abstentions from the moderators, 19 of 23 votes
were required to achieve the threshold for consensus
(80%), although because of absence from the room, occa-
sionally fewer than 23 people voted. The meeting partici-
pants voted to accept the wording presented in Table 2.
For 14 items, this meant voting for wording that modi-
Table 1. Voting responses for modification of a CONSORT item in
the pre-meeting Web-based survey and during the consensus meeting
(yes votes/total votes)
CONSORT
item
Pre-meeting
survey*
Votes to accept the
modification proposed during
the consensus meeting
1 5/25 21/21
2 6/25 21/22
3 14/23 22/22
4 4/17 20/23
5 4/20 23/23
6 4/18 22/23
7 7/21 20/23–
8 3/22 19/23
9 4/23 21/21
10 5/22 19/23
11 8/17 23/23
12 6/23 22/22
13 5/22 23/23
14 6/22 22/23
15 7/23 21/21
16 3/20 21/21
17 5/21 21/21
18 0/22 21/21
19 3/21 21/21
20 3/22 21/21
21 4/22 21/21
22 0/21 21/21
*A ‘yes’ vote indicated that the original CONSORT item (Table 3)
required modification to address intervention studies in livestock and
food safety.
A ‘yes’ vote indicated acceptance for the proposed modification as
listed in Table 3.
Item tabled and voted on at the end of the day.
–To indicate that this item was tabled.
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Table 2. Checklist of items for the REFLECT statement: reporting guidelines for randomized control trials in livestock and food safety
Paper section and topic Item Descriptor of REFLECT statement item
Reported on
page no.
Title & Abstract 1 How study units were allocated to interventions (eg, ‘random
allocation,’ ‘randomized,’ or ‘randomly assigned’). Clearly state
whether the outcome was the result of natural exposure
or was the result of a deliberate agent challenge
–
Introduction
Background
2 Scientific background and explanation of rationale –
Methods
Participants
3 Eligibility criteria for owner/managers and study units at each
level of the organizational structure, and the settings and
locations where the data were collected
–
Interventions 4 Precise details of the interventions intended for each group,
the level at which the intervention was allocated and how
and when interventions were actually administered
–
4b Precise details of the agent and the challenge model, if a
challenge study design was used
–
Objectives 5 Specific objectives and hypotheses. Clearly state primary and
secondary objectives (if applicable)
–
Outcomes 6 Clearly defined primary and secondary outcome measures and the
levels, at which they were measured and when applicable, any
methods used to enhance the quality of measurements
(e.g. multiple observations, training of assessors)
–
Sample size 7 How sample size was determined and when applicable, explanation
of any interim analyses and stopping rules. Sample-size
considerations should include sample-size determinations at
each level of the organizational structure and the
assumptions used to account for any non-independence
among groups or individuals within a group
–
Randomization – Sequence generation 8 Method used to generate the random allocation sequence
at the relevant level of the organizational structure, including
details of any restrictions (e.g. blocking, stratification)
–
Randomization – Allocation concealment 9 Method used to implement the random allocation sequence at the
relevant level of the organizational structure (e.g. numbered
containers or central telephone), clarifying whether the sequence
was concealed until interventions were assigned
–
Randomization – Implementation 10 Who generated the allocation sequence, who enrolled study units
and who assigned study units to their groups at the relevant
level of the organizational structure
–
Blinding (masking) 11 Whether or not participants those administering the interventions,
caregivers and those assessing the outcomes were blinded to group
assignment. If done, how the success of blinding was evaluated.
Provide justification for not using blinding if it was not used
–
Statistical methods 12 Statistical methods used to compare groups for all outcome(s); Clearly
state the level of statistical analysis and methods used to account
for the organizational structure, where applicable; methods for
additional analyses, such as subgroup analyses and adjusted analyses
–
Results Study flow 13 Flow of study units through each stage for each level of the
organization structure of the study (a diagram is strongly
recommended). Specifically, for each group, report the numbers of
study units randomly assigned, receiving intended treatment,
completing the study protocol and analysed for the primary outcome.
Describe protocol deviations from study as planned,
together with reasons
–
Recruitment 14 Dates defining the periods of recruitment and follow up –
Baseline data 15 Baseline demographic and clinical characteristics of each group,
explicitly providing information for each relevant level of the
organizational structure. Data should be reported in such a
way that secondary analysis, such as risk assessment, is possible
–
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fied the original CONSORT item; in the other instances,
this meant accepting no change in the wording from the
original CONSORT item; and in one instance, the vote
was to add one sub-item (Table 3). Four items (1, 5, 6
and 7) were tabled for further discussion before voting.
Tabling involved returning to the item for further discus-
sion later in the meeting. After this further discussion, the
vote was taken for the modified wording for items 1, 5
and 7 (Table 2) and to retain the exact CONSORT item
wording for item 6. The majority of changes were made
to address the issue of clustering of animal populations
(items 3, 7–13, 15). It was deemed critical that this
information be conveyed correctly to ensure understand-
ing of the study design and therefore must be part of
the CONSORT statement rather than just be further
clarified in the supporting documents. There is a need
for clear identification of the unit of allocation of the
intervention and the unit of assessment and inference.
Interventions can be allocated at any level of the organi-
zational structure and the outcome assessed at the same
or lower level. A clear understanding of the level of
allocation and outcome assessment is essential for
assessing both the internal and external validity of a
study.
Another issue was associated with the housing used
for animals. In livestock trials, non-independence of
Table 2. (Continued)
Paper section and topic Item Descriptor of REFLECT statement item
Reported on
page no.
Numbers analysed 16 Number of study units (denominator) in each group included in each
analysis and whether the analysis was by ‘intention-to-treat.’ State the
results in absolute numbers when feasible (e.g. 10/20, not 50%)
–
Outcomes and estimation 17 For each primary and secondary outcome, a summary of results
for each group, accounting for the hierarchy, and the estimated
effect size and its precision (e.g. 95% confidence interval)
–
Ancillary analyses 18 Address multiplicity by reporting any other analyses performed,
including subgroup analyses and adjusted analyses, indicating those
pre-specified and those exploratory
–
Adverse events 19 All important adverse events or side effects in each intervention group –
Discussion Interpretation 20 Interpretation of the results, taking into account study hypotheses,
sources of potential bias or imprecision, and the dangers associated
with multiplicity of analyses and outcomes. Where relevant, a
discussion of herd immunity should be included. If applicable,
a discussion of the relevance of the disease challenge
should be included
–
Generalizability 21 Generalizability (external validity) of the trial findings –
Overall evidence 22 General interpretation of the results in the context of current evidence –
Text in bold are modifications from the original CONSORT description (Moher et al., 2001a,b,c,d).
Table 3. Definitions used in the checklist for reporting trials in livestock with production, health and food-safety outcomes
Checklist description Definition
Participant The owner/manager of the study facility who consented to participate in the trial
Allocation unit The study unit allocated to receive the intervention. The allocation unit can occur at one level only of
the organizational structure
Outcome unit The study unit at which outcomes are measured. Common outcomes in livestock production include
weight gain, disease occurrence and presence or absence of an infectious disease agent. The outcome
unit can occur at one level only of the organizational structure, and may be at the same level of the
organizational structure as the allocation unit, or at a lower level
Primary outcome The primary outcome refers to the outcome measure used to determine the study sample size
Secondary outcome Another outcome measure of interest, but which was not used to determine the sample size
Organizational structure Organizational structure refers to the manner, in which the allocation and outcome units are organized
within a production system. The structure may not always be hierarchical. Knowledge of the structure is
important for understanding the internal validity of the study, particularly the appropriateness of the
data analysis. Knowledge of the structure is also important for assessing the external validity/
generalizability of the study
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observations can arise because animals are often housed
and managed in groups. Animals housed together have
something more in common than animals housed
separately, as they share the same microclimate, ration,
health-management procedures, etc. Failure to properly
account for non-independence of the data in the statisti-
cal analysis results in a violation of the association of
independence that underlies many statistical procedures.
For example, beef calves at several cow-calf farms may be
allocated to treatment and then transported to several
feedlots, where calves from multiple farms are commin-
gled in pens. Calves from the same farm or housed in the
same pen or feedlot have something more in common
than calves at a different farm or in a different pen or
feedlot. This organizational structure must be conveyed
and accounted for in the analysis. In the above example,
the organizational structure is not hierarchical, as the
farm is not always nested within pens or feedlot, i.e.,
calves from one farm may go to multiple pens or feedlots.
In other studies, the organizational structure may be hier-
archical. For example, swine may be studied within pens,
within barns, within sites and within production compa-
nies. In poultry studies, hens may be studied in multi-hen
cages within houses, within sites and within production
companies. As the organizational structure is not always
hierarchical, the recommendation is to use the term
‘organizational structure’ rather than ‘hierarchy’ when
requesting this information. Attendees agreed that, in
addition to modifying several of the items, further discus-
sion of this issue would be included in an explanation
and elaboration document.
The proposed additional item (sub-item 4b) referred to
challenge studies. Livestock trials with production, health
and food-safety outcomes are frequently conducted in
research settings, in which experimental challenge of trial
animals (often with pathogenic organisms) is under the
control of the researcher. Many of the issues of allocation
to treatment and blinding apply equally to field and
challenge studies; however, there was agreement that the
reporting of the challenge regimen was critical to under-
standing a study, but was poorly reported in many studies.
Therefore, this additional item (4b) and the corresponding
explanation and elaboration were added. Other modifica-
tions that addressed challenge studies included items 1
and 20.
In addition, the use of ‘participant’ in the original
CONSORT statement was limited to refer to animals’
owners/managers, who consent to participate in the trial.
The term ‘study unit’ was preferred for the units within
the study. Study units may further be classified as ‘alloca-
tion units’ and ‘outcome units.’ For example, a study
may allocate udder halves to receive the treatment, there-
fore the allocation unit is the udder half; however, the
outcome may be measured on the individual teat, i.e., the
outcome unit.
Discussion
Quality reporting is essential because it allows the reader
to assess the conduct of design, analysis and reported out-
comes and make appropriate judgment about the internal
and external validity of the study. Improving the quality
of information available to end users of research, such as
veterinarians, producers, industry bodies and regulatory
authorities, was the primary motivation for this initiative.
Decision makers at all levels of animal-protein production
from the farm to the fork are constantly pressured to
provide science-based rationale for recommendations.
Without high-quality reporting, this is extremely difficult.
In recent years, several reviews have reported an erratic
quality of reporting. (O’Connor et al., 2006; Sargeant
et al., 2007; Wellman and O’Connor, 2007; Burns and
O’Connor, 2008) These reviews have shown empirical
evidence of potential biases associated with the lack of
reporting of some basic trial features, such as randomiza-
tion and blinding (items 8–11) (Burns and O’Connor,
2008). In these instances, there is good indication for the
inclusion of the item in the checklist. For other modifica-
tions, clear evidence of bias introduced by failure to
report the item has not been documented. However, the
request for information about the challenge model used
(if it was a challenge study) and about the organization
of animal housing are all directed at allowing the con-
sumers of the research to determine if the study design
applies to their application. These issues affect the inter-
nal and external validity of the trial. As an example of the
impact of animal housing, a feedlot veterinarian may
expect a different outcome from a vaccine allocated to
individual animals, compared with group-level applica-
tion. Similarly, a challenge study that used 100 times the
normal dose of Salmonella to induce Salmonella shedding
may have questionable external validity. The CONSORT
statement modifications should help the researcher report
the study in such a manner that the unit of allocation
and the organizational structure of the data are discern-
ible, and provide a more structured framework for discus-
sion of how these issues affected the analysis.
We believe that reporting trials using the modified
CONSORT statement, i.e. the REFLECT statement for
livestock and food safety as a minimum standard, will
substantially improve the reporting of trials on produc-
tion, health and food-safety outcomes. Although the
REFLECT statement directly applies to reporting of stud-
ies, it may also be consulted and useful in the design and
conduct stages of a trial. Researchers may find it helpful
when designing trials to consider items that will be
A. M. O’Connor et al. REFLECT Statement
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requested in the report of the trial. Considering the ratio-
nale behind the requirement for each checklist item, be it
internal validity, external validity or both may lead to a
better design. The rationale for the inclusion of each item,
and examples of how to report livestock trials with
production, health and food-safety outcomes, are con-
tained in a companion Example and Elaboration Docu-
ment (Sargeant et al., 2010a,b).
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